期刊文献+

石墨炉原子吸收光谱法测定血浆中铂 被引量:5

GF-AAS Determination of Platinum in Human Plasma
下载PDF
导出
摘要 提出了石墨炉原子吸收光谱法测定顺铂人血浆中铂浓度。采集人静脉血作样品,用浓硝酸及过氧化氢消解。冷却至4℃,使脂肪固化并过滤除去。收集滤液,蒸干,用200μL盐酸(1+99)溶液浸取残渣,所得溶液供石墨炉原子吸收光谱分析。方法的线性范围为0.02~1.00mg.L-1,检出限(3σ)为0.016mg·mL-1,回收率在94.6%~120.0%之间,相对标准偏差(n=5)小于7%。 A method for determination of platinum in human plasma released from the sustained-release implant of cis-platinum by GF-AAS was proposed. Veinous blood was taken as sample and digested with conc. HNO3 and H2O2. The clear digested solution was cooled to 4 ℃to solidify fat which was then separated by filtration. The filtrate was collected and evaporated to dryness, the residue was taken up with 200 μL of HCl(1+99) and used for GF-AAS analysis under the optimized conditions. Linear relationship was obtained between values of absorbance and mass concentration of Pt(Ⅳ) in the range from 0.02-1.00 mg·L-1 Detection limit (3a) of the method was found to be 0. 016mg·L-1 Recovery and precision were tested on the base of simulated samples by standard addition method, giving values of recovery in the range from 94. 6% to 120. 0%, and values of RSD's (n= 5) less than 7%.
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2010年第3期257-259,共3页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
基金 安徽省十一五科技攻关重点项目(06013062A)
关键词 石墨炉原子吸收光谱法 铂(Ⅳ) 顺铂 血浆 GF-AAS Platinum(Ⅳ) cis-Platinum Blood plasma
  • 相关文献

参考文献9

  • 1VEAL G J, DIAS C, PRICE L, et al. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy[J]. Clin Cancer Res, 2001,7 (8) :2205-2212.
  • 2LOPEZ-FLORES A, JURADO R, GARCIA-LOPEZ P. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples[J]. J Pharmacol Toxicol Methods, 2005,52(3) :366-372.
  • 3LANJWANI S N, ZHU R, KHUHAWAR M Y, et al. High performance liquid chromatographic determination of platinum in blood and urine samples of cancer patients after administration of cisplatin drug using solvent extraction and N, N'-bis(salicylidene)-1, 2-propanediamine as complexation reagent[J]. J Pharm Biomed Anal, 2006,40(4):833-839.
  • 4GELEVERT T, MESSERSCHMIDT J, MAEINAR- DI M T, et al. Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin[J]. Ther Drug Monit, 2001,23(2) : 169-173.
  • 5杨叶梅,贺与平,陈金素,李坚.ICP-AES法测定顺铂、卡铂血药浓度[J].中国卫生检验杂志,2000,10(3):259-261. 被引量:11
  • 6徐志洲,张桂芳.络合量法测定顺铂的含量[J].药物分析杂志,2001,21(1):44-45. 被引量:3
  • 7HUANG Z, TIMERBAEV A R, KEPPLER B K, et al. Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques[J]. J Chromatogr A, 2006,1106(1/2) :75-79.
  • 8PENDYALA L, SCHWARTZ G, SMITH P, et al. Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy[J]. Cancer Chemother Pharmacol, 2003, 51 (5) : 376-384.
  • 9ZAMBONI W C, GERVAIS A C, EGORIN M J, et al. Inter-and intratumoral disposition of platinum in solid tumors after administration of cisplatin[J]. Clin Cancer Res, 2002,8(9) : 2992-2999.

二级参考文献4

  • 1孙泰光 陈玉石 等.原子吸收光谱法测定顺铂血药浓度[J].中国医院药学杂志,1988,8(7):322-322.
  • 2中国药典(二部 ),1995年,526页
  • 3陈永兆,络合滴定,1986年,300页
  • 4李水林,金一,李风龙.顺铂复合型乳剂的研究[J].延边医学院学报,1990,13(3):182-186. 被引量:5

共引文献12

同被引文献39

  • 1李杰,安鸿志,刘彩玉.高效液相色谱法测定人血浆中顺铂的含量[J].中国药房,2006,17(18):1399-1400. 被引量:7
  • 2储成顶,成微,王世亮,刘飞,俞敏,鲍玉婷.缓释植入剂局部给药治疗系统的药动学模型[J].中国新药杂志,2004,13(7):613-616. 被引量:23
  • 3王娟,陈峻青.卡铂腹腔化疗药代动力学实验研究[J].中华肿瘤杂志,1994,16(3):196-198. 被引量:92
  • 4Chaney S G,Campbell S L,Bassett E,et al. Recognition and processing of cisplatin- and oxaliplatin DNA adducts[J]. Crit Rev Oncol He matol,2005,53(1) :3-11.
  • 5Feng Z, Li W, Xue X, et al. A Novel GAP460 Biopolymer for Use as a Carrier in Drug Delivery Applications [J]. Biomater Sci Polym Ed, 2011,22(15) .- 2023-2040.
  • 6Zahid H S,Frances E B,Kenneth R H. Flameless atomic absorption spectrophotometric determination ot platinum in tissues solubilized m hyamlne hydroxide[J]. Analytical Biochemistry, 1987,163 (1) .- 21-26.
  • 7BARABS K,MILNER R, LURIE D, et al. Cisplatin : a review oftoxicties and therapeutic applications [ J ]. Vet Comp Oncol ,200S ,6(1) :1 -18.
  • 8BOSCH ME,SANCHEZ AJ,ROJAS ?S,et al. Analytical method-ologies for the determination of cisplatin [ J ] . Pharm Biomed A-na/,2008,47(3) :451 -459.
  • 9GUCHEL AAR HJ,DE VRIES EG,MEIJER C,et al. Effect ofultrafilterable platinum concentration on cisplatin and carboplatincytotoxicity in human tumor and bone marroe cells in vitro [ J ].Pharm ftes, 1994 ,11 (9) :1265 - 1269.
  • 10VERMORKEN JB,VAN DER VIJGH WJ,KLEIN \,et al. Phar-macokinetics of free and total platinum species after rapid andprolonged infusions of cisplatin[ J]. Clin Pharmacol Ther,1986 ,39(2) :136 -144.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部